Your Pancreas Already Makes Its Own Version of Ozempic

Duke University scientists discovered that your pancreatic alpha cells — long thought to only produce glucagon — actually generate powerful amounts of GLP-1. These drugs mimic something your body was already supposed to be doing.

Here's a fact that changes how you think about GLP-1 medications: the hormone they mimic isn't just produced by your gut. Your pancreas makes it too. And it makes a lot of it. ScienceDaily

In September 2025, Duke University scientists published a discovery that reshaped our understanding of GLP-1 biology. They found that pancreatic alpha cells — which were long believed to only produce the hormone glucagon — actually generate significant amounts of GLP-1. This isn't a minor footnote. It's a fundamental revision of textbook endocrinology.

What This Discovery Means

For years, the prevailing understanding was simple: you eat food, your L-cells in the small intestine secrete GLP-1, the hormone helps regulate blood sugar and appetite, and then it's rapidly broken down. GLP-1 medications were seen as synthetic versions of this gut hormone, engineered to last longer in the bloodstream.

The Duke discovery adds a crucial piece to the puzzle. Your pancreas is producing its own GLP-1 locally, right next to the insulin-producing beta cells. This suggests that GLP-1 signaling within the pancreas itself is a critical part of normal metabolic regulation — and that disruption of this local signaling may contribute to diabetes and metabolic dysfunction.

Why This Matters for Patients

One of the most common concerns people have about GLP-1 medications is that they feel "unnatural" — like taking a drug to override your body's normal processes. The Duke discovery fundamentally reframes this narrative.

When you take semaglutide or tirzepatide, you're not introducing something alien to your body. You're supplementing a hormone that your body already produces in multiple locations — but perhaps not in sufficient quantities, or not with sufficient duration of action, to maintain healthy weight and metabolic function.

Think of it like supplementing thyroid hormone when your thyroid doesn't produce enough, or taking insulin when your pancreas can't keep up with demand. GLP-1 medications fill a biological gap, not create an artificial override.

The Biological Context

Your body has a sophisticated system for regulating appetite, blood sugar, and energy balance. GLP-1 is one of the key players in that system, working alongside insulin, glucagon, amylin, leptin, ghrelin, and other hormones. In people with obesity, multiple components of this system are often dysregulated — GLP-1 signaling may be blunted, insulin resistance may be present, and the appetite "set point" may be miscalibrated.

GLP-1 medications restore one of the most important components of that signaling system to therapeutic levels. They don't bypass your biology — they augment it.

Ready to Get Started?

These verified telehealth providers offer GLP-1 programs with medical oversight and home delivery:

Affiliate Disclosure: Some provider links on this page are affiliate links. If you sign up through these links, we may receive compensation at no additional cost to you. This does not influence our editorial content or provider selection.